365 related articles for article (PubMed ID: 23651418)
1. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
Iwata H; Kitajima Y
Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
3. Complement-independent blistering mechanisms in bullous pemphigoid.
Iwata H; Ujiie H
Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
5. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
[TBL] [Abstract][Full Text] [Related]
7. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
Nishie W
J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
[TBL] [Abstract][Full Text] [Related]
8. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and practical diagnosis of bullous pemphigoid.
Schmidt E; della Torre R; Borradori L
Immunol Allergy Clin North Am; 2012 May; 32(2):217-32, v. PubMed ID: 22560135
[TBL] [Abstract][Full Text] [Related]
11. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
[TBL] [Abstract][Full Text] [Related]
14. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
15. Role of BP230 autoantibodies in bullous pemphigoid.
Shih YC; Wang B; Yuan H; Zheng J; Pan M
J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
17. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
18. Complement and cutaneous autoimmune blistering diseases.
Lessey E; Li N; Diaz L; Liu Z
Immunol Res; 2008; 41(3):223-32. PubMed ID: 18641925
[TBL] [Abstract][Full Text] [Related]
19. Human skin basement membrane in health and in autoimmune diseases.
Chan LS
Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
